Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 117
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Pediatr Dermatol ; 39(2): 320-321, 2022 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-35014095

RESUMEN

Contact dermatitis usually presents as erythematous macules, papules, and vesicles. Sometimes, unusual clinical presentations of contact dermatitis are reported, including pustular, lymphomatoid, lichenoid, and pigmented variants. We describe the first patient with bullous irritant contact dermatitis caused by perfume, mimicking impetigo lesions. We report this case to raise awareness concerning the possibility of serious cutaneous reactions, such as bullous impetigo-like irritant contact dermatitis due to perfumes which are ubiquitous, especially after direct contact with the solution. Perfume ingredients, such as fragrance, solvents, and preservatives all may cause or contribute to irritant contact dermatitis.


Asunto(s)
Dermatitis Alérgica por Contacto , Dermatitis por Contacto , Dermatitis Irritante , Impétigo , Perfumes , Traumatismos de los Tejidos Blandos , Dermatitis Alérgica por Contacto/etiología , Dermatitis por Contacto/etiología , Dermatitis Irritante/diagnóstico , Dermatitis Irritante/tratamiento farmacológico , Dermatitis Irritante/etiología , Humanos , Impétigo/diagnóstico , Impétigo/tratamiento farmacológico , Irritantes
2.
Contact Dermatitis ; 85(4): 387-397, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34324721

RESUMEN

Interleukin-1ß (IL-1ß) is an important pro-inflammatory cytokine that has an effect on almost every cell lineage in the body. By blocking IL-1ß and investigating the IL-1ß signaling pathway, several studies have demonstrated a central role of IL-1ß in the response to contact allergens. This review summarizes the current literature regarding the basic immunological mechanisms mediated by IL-1ß in the different phases of allergic contact dermatitis (ACD) and highlights potential IL-1ß-targeted treatment options, which in the future may be relevant in the treatment of patients with ACD. This review is based primarily on studies using various mouse models and human in vitro studies, since clinical studies on the effect of IL-1ß in ACD are lacking.


Asunto(s)
Dermatitis Alérgica por Contacto/inmunología , Interleucina-1beta/inmunología , Alérgenos/inmunología , Animales , Dermatitis Alérgica por Contacto/tratamiento farmacológico , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/inmunología , Dermatitis Irritante/tratamiento farmacológico , Dermatitis Irritante/inmunología , Modelos Animales de Enfermedad , Humanos , Interleucina-1beta/antagonistas & inhibidores , Receptores de Interleucina-1/antagonistas & inhibidores , Receptores de Interleucina-1/inmunología , Transducción de Señal
3.
Br J Dermatol ; 181(1): 175-185, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-30637727

RESUMEN

BACKGROUND: Sodium lauryl sulfate (SLS)-induced contact dermatitis is a commonly used model for testing the effects of different topical formulations. According to the guidelines, the volar forearms are the preferred testing site; however, other anatomical locations have been used in previous research, particularly the upper back as the clinically used site for testing different antigens. OBJECTIVES: To investigate the existence of anatomical variations of the skin response to irritation and its effects on the response to treatment. METHODS: Irritation was induced with SLS on symmetrical sites on both forearms and sides of the upper back with additional sites exposed to water as controls. Half of the sites were treated with emollient cream while the other half were left untreated. Irritation was assessed using bioengineering methods and clinical scoring. The trial was registered at ClinicalTrials.gov as NCT03231813. RESULTS: Upper back skin showed higher reactivity to irritants with stronger barrier disruption (measured by Tewameter® , 80·2 ± 18·3 vs. 48·0 ± 24·2 g m-2  h-1 ), more pronounced erythema (measured by Mexameter® , 186·5 ± 88·4 vs. 92·1 ± 58·2 arbitrary units) and dryness (measured by Corneometer® , -28·6 ± 14·5 vs. 2·7 ± 16·9 arbitrary units). Skin recovery rates were also influenced by anatomical location with the upper back showing faster recovery (316·7 ± 223·1 vs. 156·2 ± 198·5). Treatment did not lead to improvement in measured parameters, regardless of anatomical location. CONCLUSIONS: The skin's reaction to irritant and recovery was dependent on anatomical location. The location where testing was conducted should always be reported, as treatments tested across different locations could not be directly compared with each other.


Asunto(s)
Dermatitis Irritante/diagnóstico , Emolientes/uso terapéutico , Irritantes/toxicidad , Piel/efectos de los fármacos , Dodecil Sulfato de Sodio/toxicidad , Administración Cutánea , Adulto , Dorso , Dermatitis Irritante/tratamiento farmacológico , Dermatitis Irritante/etiología , Emolientes/farmacología , Femenino , Antebrazo , Voluntarios Sanos , Humanos , Masculino , Índice de Severidad de la Enfermedad , Crema para la Piel/farmacología , Crema para la Piel/uso terapéutico , Resultado del Tratamiento , Pérdida Insensible de Agua/efectos de los fármacos , Adulto Joven
4.
Orbit ; 38(2): 112-118, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29985741

RESUMEN

PURPOSE: To better understand the nature of periocular dermatitis (PD) patient presentation, treatment, time-to-cure, and referral pattern for allergy testing in an ophthalmic academic center. METHODS: A retrospective chart review of 344 patients diagnosed with PD between January 1, 2000 and November 30, 2016 at the Edward S. Harkness Eye Institute was performed. Eighty patients were eligible for the study. The primary endpoint was the time-to-cure. Cox proportional hazards regression was performed to assess if there was a significant difference between time-to-cure in patients treated with: 1) combination topical steroid/antibiotic (n = 6) vs. topical steroid alone (n = 40) and 2) combination topical steroid and oral antihistamine (n = 5) vs. topical steroid alone (n = 40). RESULTS: The median age of eligible patients was 57.69 years old, 66.25% of patients were female, and 41.25% had a history of atopy. Seven patients in total were referred for allergy testing. A significant difference was found in likelihood of cure when comparing combination topical steroid and oral antihistamine versus topical steroid alone, adjusting for age and gender (aHR = 3.97, 95% CI: 1.40-11.25). No significance was found when comparing combination topical steroid/antibiotic versus topical steroid alone (aHR = 1.96, 95% CI: 0.72-5.27). CONCLUSION: Patients treated with topical steroid and oral antihistamine were approximately 4 times more likely to experience cure in comparison to patients treated with topical steroids alone. While the majority of patients were not referred for formal allergy testing, this would likely be of benefit.


Asunto(s)
Dermatitis Alérgica por Contacto/diagnóstico , Dermatitis Atópica/diagnóstico , Dermatitis Irritante/diagnóstico , Enfermedades de los Párpados/diagnóstico , Centros Médicos Académicos , Administración Oftálmica , Administración Oral , Adulto , Anciano , Antialérgicos/uso terapéutico , Antibacterianos/uso terapéutico , Dermatitis Alérgica por Contacto/tratamiento farmacológico , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Irritante/tratamiento farmacológico , Quimioterapia Combinada , Enfermedades de los Párpados/tratamiento farmacológico , Femenino , Fluorometolona/uso terapéutico , Glucocorticoides/uso terapéutico , Humanos , Hidrocortisona/uso terapéutico , Etabonato de Loteprednol/uso terapéutico , Masculino , Persona de Mediana Edad , New York , Soluciones Oftálmicas , Oftalmología , Modelos de Riesgos Proporcionales , Derivación y Consulta , Estudios Retrospectivos
5.
Contact Dermatitis ; 76(3): 131-137, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-27418013

RESUMEN

BACKGROUND: Irritant contact dermatitis is caused by skin barrier damage. Vitamin E is an antioxidant that is commonly used in cosmetics to prevent photo-damage. OBJECTIVES: To show the usefulness of reflectance confocal microscopy in the assessment of irritant skin damage caused by sodium lauryl sulfate (SLS) and of the protective action of vitamin E applied prior to skin irritation. METHODS: Ten healthy volunteers were enrolled. Irritation was induced by the application of a patch test containing SLS 5% aq. for 24 h. Three sites were compared: one site on which a product with vitamin E was applied before SLS treatment, one site on which the same product was applied after SLS treatment, and one control site (SLS only). Each site was evaluated with reflectance confocal microscopy, providing in vivo tissue images at nearly histological resolution. We also performed a computerized analysis of the VivaStack® images. RESULTS: Reflectance confocal microscopy is able to identify signs of skin irritation and the preventive effect of vitamin E application. CONCLUSION: Reflectance confocal microscopy is useful in the objective assessment of irritative skin damage.


Asunto(s)
Antioxidantes/uso terapéutico , Dermatitis Irritante/tratamiento farmacológico , Dermatitis Irritante/patología , Vitaminas/uso terapéutico , Adulto , Femenino , Humanos , Irritantes/efectos adversos , Masculino , Microscopía Confocal , Pruebas de Irritación de la Piel , Dodecil Sulfato de Sodio/efectos adversos
6.
Br J Nurs ; 26(5): S12-S19, 2017 Mar 09.
Artículo en Inglés | MEDLINE | ID: mdl-28328276

RESUMEN

Individuals living with an ostomy may suffer from a variety of peri-stomal skin complications related to the use of their stoma appliance or accessories. These conditions can be serious enough to significantly impact on a patient's quality of life and may result in severe clinical complications (such as infection). This article is a review of the literature with the objective of investigating and presenting evidence for the well-documented use of aloe vera in the prevention of skin conditions similar to those seen in peri-stomal skin complications. An exploration for the potential use of aloe vera directly or indirectly (as an adjunct to medical devices such as wafers) in stoma patients is presented with the view that this use may be beneficial in the prevention of such peri-stomal skin complications.


Asunto(s)
Aloe , Estomía/enfermería , Preparaciones de Plantas/uso terapéutico , Cuidados de la Piel/métodos , Dermatitis Alérgica por Contacto/tratamiento farmacológico , Dermatitis Alérgica por Contacto/prevención & control , Dermatitis Irritante/tratamiento farmacológico , Dermatitis Irritante/prevención & control , Humanos , Piodermia Gangrenosa/tratamiento farmacológico , Piodermia Gangrenosa/prevención & control , Enfermedades Cutáneas Infecciosas/tratamiento farmacológico , Enfermedades Cutáneas Infecciosas/prevención & control
7.
Dermatology ; 232(3): 353-62, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26990096

RESUMEN

INTRODUCTION: Skin tissue is frequently exposed to various irritant substances in the workplace, particularly in wet work, which can lead to the development of occupational contact dermatitis. 'Barrier' creams (BCs) are well known, and their applications are still the subject of many studies and controversies. METHODS: We searched all controlled trials investigating BCs against cutaneous irritants in humans published between 1956 and December 2014 from MEDLINE, PubMed, reference lists and existing reviews. RESULTS: Thirty-nine studies about the effects of BCs against skin irritants in humans were selected. Among these, 27 trials in healthy volunteers were found to show many differences with regard to BCs and irritants used, their quantities, test locations, procedures and assessment methods. Finally, 14 patch test trials assessed by clinical scoring and evaporimetry emerged. Although the findings were generally positive, only few findings could be cross-checked from all the data, and vehicles seem to be as effective as BCs. CONCLUSION: Although this review highlights the poor quality and the lack of standardization of most studies, BCs seem to have protective effects against irritants. Further well-designed, adequately powered randomized controlled trials with clinical and biophysical assessments are required.


Asunto(s)
Dermatitis Irritante/tratamiento farmacológico , Dermatitis Profesional/tratamiento farmacológico , Crema para la Piel/administración & dosificación , Humanos , Resultado del Tratamiento
8.
J Drugs Dermatol ; 15(11): s81-s85, 2016 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-28095569

RESUMEN

BACKGROUND: Occupational irritant contact dermatitis (OICD) is a dif cult and hard to manage condition. It occurs more frequently in certain occupations where contact with harsh chemicals, use of alcohol-based disinfectants, and frequent hand washing heightens the risk. Treatment for OICD includes patient education in addition to physical, topical, and systemic therapies. OBJECTIVE: To review the pathogenesis and treatment options for OICD and evaluate the ef cacy of a selective skin-care regimen involv- ing a hand protectant cream alone as well as combined with a repair cream and speci c cleanser. MATERIALS AND METHODS: A single-center open study was performed comprising 42 healthy male and female adult volunteers prone to occupational irritant contact dermatitis due to frequent wet work or contact with detergents. Between day 0 and day 7, subjects applied a hand protectant cream as needed on both hands (at least twice daily). On days 7 to 14, subjects applied a hand protectant cream and cleanser as needed on both hands (at least twice daily) as well as a repair cream each evening. A diary log was given to each volunteer for application control and for a subjective evaluation of daily tolerability. RESULTS: In these subjects prone to occupational irritant contact dermatitis, the hand protectant cream applied during the initial 7-day period was effective in restoring the damaged skin barrier and improving the stratum corneum hydration. A regimen that combined the hand protectant and repair creams with a speci c cleanser during a further 7-day period allowed contin- ued improvement of skin hydration and additional clinical bene ts while respecting the skin barrier function. CONCLUSION: The results of this study support the use of a 3-step approach for patients who are at risk of repeated exposure to external irritants. J Drugs Dermatol. 2016;15(suppl 11):s81-85..


Asunto(s)
Dermatitis Irritante/tratamiento farmacológico , Exposición Profesional/efectos adversos , Cuidados de la Piel/métodos , Crema para la Piel/administración & dosificación , Piel/efectos de los fármacos , Adulto , Dermatitis Irritante/diagnóstico , Dermatitis Irritante/etiología , Femenino , Desinfección de las Manos/métodos , Humanos , Masculino , Piel/patología , Resultado del Tratamiento , Pérdida Insensible de Agua/efectos de los fármacos
9.
Contact Dermatitis ; 75(4): 205-12, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27356809

RESUMEN

BACKGROUND: A tertiary individual prevention programme (TIP) is offered to patients with severe occupational skin disease (OSD) in Germany. Previously, it was shown that the burden of OSDs is considerably reduced in patients up to 1 year after the TIP. OBJECTIVES: To evaluate the long-term effects of the TIP. PATIENTS AND METHODS: In a prospective multicentre cohort study, the clinical and patient-reported outcome data 3 years after the TIP were evaluated. RESULTS: Of the 1788 patients initially included in the study, 1410 were available for the 3-year follow-up analysis. The severity of OSD, the use of topical corticosteroids and days of absence from work were significantly reduced 3 years after the TIP, and the quality of life and skin protective behaviour were significantly improved. Of the patients, 96.9% were able to resume work. One thousand one hundred and sixty-six patients (82.7%) were still working 3 years after the TIP, 874 of them (75.0%) in the same occupational field. Hairdressers had the lowest rate of remaining in their original profession (41.3%). CONCLUSIONS: The follow-up during 3 years of this unique cohort of patients with OSDs shows that the TIP is associated with sustained improvements in terms of disease severity, ability to work, quality of life, and prognosis.


Asunto(s)
Dermatitis Alérgica por Contacto/rehabilitación , Dermatitis Irritante/rehabilitación , Dermatitis Profesional/rehabilitación , Dermatosis de la Mano/rehabilitación , Calidad de Vida , Reinserción al Trabajo , Prevención Terciaria/métodos , Administración Cutánea , Corticoesteroides/uso terapéutico , Adulto , Estudios de Cohortes , Industria de la Construcción , Dermatitis Alérgica por Contacto/tratamiento farmacológico , Dermatitis Irritante/tratamiento farmacológico , Dermatitis Profesional/tratamiento farmacológico , Femenino , Manipulación de Alimentos , Alemania , Dermatosis de la Mano/tratamiento farmacológico , Sector de Atención de Salud , Hospitalización , Humanos , Estudios Longitudinales , Masculino , Metales , Persona de Mediana Edad , Medición de Resultados Informados por el Paciente , Estudios Prospectivos , Garantía de la Calidad de Atención de Salud , Ausencia por Enfermedad/estadística & datos numéricos , Resultado del Tratamiento
10.
Pediatr Dermatol ; 33(3): 332-6, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-27040137

RESUMEN

BACKGROUND/OBJECTIVE: Diaper dermatitis (DD) is a common infantile dermatosis with a highly variable prevalence and incidence. This study aimed to present the demographic and clinical features of babies with DD. METHODS: Data, including demographic and clinical features, obtained from DD patient forms were retrospectively analyzed. RESULTS: The study included 63 babies with DD (female: n = 35 [55.6%]; male: n = 28 [44.4%]; mean age 11.6 mos). Most of the patients (43.5%) were 0 to 6 months of age. In all, 76.3% were breastfed, of whom 31.7% were exclusively breastfed. The number of previous episodes of DD was significantly lower in breastfed babies. The most common diaper area cleansing method was wet wipes (54.1%). Diaper creams were used in 86.2% of patients. DD was severe in 22.2% of patients, moderate in 57.4%, and mild in 20.4%. Candida infection was noted in 77.4% of patients. The median number of previous episodes of DD was significantly higher in patients with Candida infection than in those without (p = 0.02). Treatment yielded greater than 50% improvement (complete and moderate response) in 59.4% of patients at the first follow-up visit (3-5 days) and 82.6% at the second follow-up visit (10 days). CONCLUSION: Most babies with DD were 0 to 6 months of age. Breastfed babies had fewer previous episodes of DD, so mothers should be encouraged to breastfeed their babies to reduce the incidence of DD. Candida infection was common; clinicians should be aware of its association with DD.


Asunto(s)
Fármacos Dermatológicos/uso terapéutico , Dermatitis del Pañal/diagnóstico , Dermatitis del Pañal/tratamiento farmacológico , Cuidados de la Piel/métodos , Administración Tópica , Antifúngicos/uso terapéutico , Distribución de Chi-Cuadrado , Bases de Datos Factuales , Dermatitis Irritante/diagnóstico , Dermatitis Irritante/tratamiento farmacológico , Dermatitis Irritante/epidemiología , Dermatitis del Pañal/epidemiología , Femenino , Humanos , Incidencia , Lactante , Recién Nacido , Masculino , Prednisolona/uso terapéutico , Estudios Retrospectivos , Medición de Riesgo , Índice de Severidad de la Enfermedad , Estadísticas no Paramétricas , Resultado del Tratamiento
12.
J Eur Acad Dermatol Venereol ; 29(12): 2333-41, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26370610

RESUMEN

BACKGROUND: Glycerol is known to possess anti-irritant and hydrating properties and previous studies suggested that xylitol may also have similar effects. OBJECTIVE: Our aim was to study whether different concentrations of these polyols restore skin barrier function and soothe inflammation in sodium lauryl sulphate (SLS)-induced acute irritation. METHODS: The experiments were performed on male SKH-1 hairless mice. The skin of the dorsal region was exposed to SLS (5%) for 3 h alone or together with 5% or 10% of glycerol respectively. Further two groups received xylitol solutions (8.26% and 16.52% respectively) using the same osmolarities, which were equivalent to those of the glycerol treatments. The control group was treated with purified water. Transepidermal water loss (TEWL) and skin hydration were determined. Microcirculatory parameters of inflammation were observed by means of intravital videomicroscopy (IVM). Furthermore, accumulation of neutrophil granulocytes and lymphocytes, the expression of inflammatory cytokines and SLS penetration were assessed, as well. RESULTS: Treatment with the 10% of glycerol and both concentrations of xylitol inhibited the SLS-induced elevation of TEWL and moderated the irritant-induced increase in dermal blood flow and in the number of leucocyte-endothelial interactions. All concentrations of the applied polyols improved hydration and prevented the accumulation of lymphocytes near the treatment site. At the mRNA level, neither glycerol nor xylitol influenced the expression of interleukin-1 alpha. However, expression of interleukin-1 beta was significantly decreased by the 10% glycerol treatment, while expression of tumour necrosis factor-alpha decreased upon the same treatment, as well as in response to xylitol. Higher polyol treatments decreased the SLS penetration to the deeper layers of the stratum corneum. CONCLUSION: Both of the analysed polyols exert considerable anti-irritant and anti-inflammatory properties, but the effective concentration of xylitol is lower than that of glycerol.


Asunto(s)
Dermatitis Irritante/tratamiento farmacológico , Emolientes/uso terapéutico , Glicerol/uso terapéutico , Fenómenos Fisiológicos de la Piel/efectos de los fármacos , Piel/metabolismo , Xilitol/uso terapéutico , Animales , Dermatitis Irritante/etiología , Dermatitis Irritante/patología , Emolientes/farmacología , Expresión Génica/efectos de los fármacos , Glicerol/farmacología , Interleucina-1alfa/genética , Interleucina-1beta/genética , Microscopía Intravital , Masculino , Ratones , Ratones Pelados , Permeabilidad/efectos de los fármacos , Flujo Sanguíneo Regional/efectos de los fármacos , Piel/irrigación sanguínea , Piel/química , Dodecil Sulfato de Sodio/farmacocinética , Factor de Necrosis Tumoral alfa/genética , Agua/análisis , Pérdida Insensible de Agua/efectos de los fármacos , Xilitol/farmacología
13.
Artículo en Inglés | MEDLINE | ID: mdl-26513900

RESUMEN

A 30-year-old Chinese female presented with progressive periorbital swelling of unknown cause and redness of her left eye. She was given an antibiotic eyedrop and oral cloxacillin to treat periorbital cellulitis. The clinical picture did not improve and she returned with swelling of the fellow eye. We stopped the medication and sent her to a dermatologist because of the abnormal periorbital skin pattern. Her diagnosis was Paederus dermatitis. Intramuscular dexamethasone was administered due to severe periorbital edema. The skin lesion was improved one week later. The ophthalmic manifestations of Paederus dermatitis are periorbital dermatitis, conjunctivitis and persistent epithelial defects. The challenge in diagnosis of this condition is that it can mimic other diseases, such as infectious periorbital cellulitis and Herpes viral infection. Therefore, a clear appreciation of the clinical manifestations will lead us to the proper management of the condition and minimize complications.


Asunto(s)
Dermatitis Irritante/parasitología , Oftalmopatías/parasitología , Adulto , Animales , Antibacterianos/uso terapéutico , Escarabajos , Dermatitis Irritante/diagnóstico , Dermatitis Irritante/tratamiento farmacológico , Diagnóstico Diferencial , Edema/etiología , Femenino , Humanos
15.
Australas J Dermatol ; 55(4): 275-8, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25178716

RESUMEN

We report two cases of adults with urticarial dermatitis who could not be managed by a variety of treatments but who obtained good control with mycophenolate mofetil (MMF). A clinical response was seen 6-8 weeks from treatment onset and they were maintained on MMF 1 g twice daily (case 1), and MMF 1 g omni mane and 500 mg omni nocte (case 2), with no major exacerbations for many years. MMF is an immunosuppressive agent, which is currently used off-label for many dermatological conditions. To date, there have been no studies investigating the use of MMF as a treatment for urticarial dermatitis. The cases we present suggest that MMF is an effective treatment for this condition, and we recommend that MMF be considered as a treatment option.


Asunto(s)
Dermatitis Irritante/tratamiento farmacológico , Inmunosupresores/uso terapéutico , Ácido Micofenólico/análogos & derivados , Urticaria/tratamiento farmacológico , Corticoesteroides/uso terapéutico , Enfermedad Crónica , Dermatitis Irritante/radioterapia , Humanos , Masculino , Persona de Mediana Edad , Ácido Micofenólico/uso terapéutico , Retratamiento , Terapia Ultravioleta , Urticaria/radioterapia
16.
Cutan Ocul Toxicol ; 33(1): 87-9, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23883334

RESUMEN

Chemical hair removal products are available as creams, gels, powders, aerosols and roll-ons and all of these forms work in the same way by breaking chemical bonds between sulfur atoms in the protein. Currently, the common active ingredients of these products are calcium thioglycolate, potassium thioglycolate, arsenic and sulfur minerals. Sulfur and arsenic containing products are important toxic chemicals which are mainly used for removing hair in developing countries. Irritant contact dermatitis accounts for 80% of all contact dermatitis reactions which are often occupation-related. Toluene sulfonamide, formaldehyde resin, acrylates and ethylcyanoacrylate are the most common irritants. Irritant nail dermatitis with plants has been well defined with Lobelia richardii flower, Compositae family and garlic. Although allergic dermatitis, irritant dermatitis and irritant nail dermatitis have been well demonstrated with chemicals, koilonychia is unusual presentation of irritant dermatitis. Here we describe a case of nail irritant dermatitis due to application of chemical depilatory product for hair removal presented with koilonychias. To our knowledge this is the first case of such presentation with koilonychia in the English literature.


Asunto(s)
Arsenicales/efectos adversos , Dermatitis Irritante/etiología , Remoción del Cabello , Uñas Malformadas/etiología , Compuestos de Azufre/efectos adversos , Corticoesteroides/administración & dosificación , Corticoesteroides/uso terapéutico , Adulto , Dermatitis Irritante/diagnóstico , Dermatitis Irritante/tratamiento farmacológico , Emolientes/administración & dosificación , Emolientes/uso terapéutico , Femenino , Humanos , Uñas Malformadas/diagnóstico , Uñas Malformadas/tratamiento farmacológico , Resultado del Tratamiento
17.
Br J Pharmacol ; 181(8): 1256-1267, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-37990638

RESUMEN

BACKGROUND AND PURPOSE: Glucocorticoids are powerful anti-inflammatory drugs, but are associated with many side-effects. Topical application in atopic dermatitis leads to skin thinning, metabolic changes, and adrenal suppression. 5α-Tetrahydrocorticosterone (5αTHB) is a potential selective anti-inflammatory with reduced metabolic effects. Here, the efficacy and side-effect profile of 5αTHB were compared with hydrocortisone in preclinical models of irritant dermatitis. EXPERIMENTAL APPROACH: Acute irritant dermatitis was invoked in ear skin of male C57BL/6 mice with a single topical application of croton oil. Inflammation was assessed as oedema via ear weight following treatment with 5αTHB and hydrocortisone. Side-effects of 5αTHB and hydrocortisone were assessed following chronic topical steroid treatment (28 days) to non-irritated skin. Skin thinning was quantified longitudinally by caliper measurements and summarily by qPCR for transcripts for genes involved in extracellular matrix homeostasis; systemic effects of topical steroid administration also were assessed. Clearance of 5αTHB and hydrocortisone were measured following intravenous and oral administration. KEY RESULTS: 5αTHB suppressed ear swelling in mice, with ED50 similar to hydrocortisone (23 µg vs. 13 µg). Chronic application of 5αTHB did not cause skin thinning, adrenal atrophy, weight loss, thymic involution, or raised insulin levels, all of which were observed with topical hydrocortisone. Transcripts for genes involved in collagen synthesis and stability were adversely affected by all doses of hydrocortisone, but only by the highest dose of 5αTHB (8× ED50 ). 5αTHB was rapidly cleared from the systemic circulation. CONCLUSIONS AND IMPLICATIONS: Topical 5αTHB has potential to treat inflammatory skin conditions, particularly in areas of delicate skin.


Asunto(s)
Corticosterona/análogos & derivados , Dermatitis Irritante , Glucocorticoides , Ratones , Masculino , Animales , Hidrocortisona , Modelos Animales de Enfermedad , Ratones Endogámicos C57BL , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Dermatitis Irritante/tratamiento farmacológico , Administración Tópica
20.
Australas J Dermatol ; 54(2): 136-8, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23581998

RESUMEN

A 26-year-old Australian female traveller in Sierra Leone presented with an irritant bullous contact dermatitis consistent with paederus dermatitis. The lesions were treated with a potent topical corticosteroid with good effect. The affected area resolved in 6 weeks and hyperpigmention persisted for months until complete resolution. This dermatitis occurs when beetles of the genus Paederus (rove beetles) are crushed on the skin, releasing pederin. The same dermatitis ensues with Australian Paederus species. Serial clinical photographs are presented which will aid Australian dermatologists in the diagnosis of this dermatitis, which presents in regional Australian patients and returned overseas travellers.


Asunto(s)
Escarabajos , Dermatitis Irritante/etiología , Dermatitis Irritante/patología , Adulto , Animales , Antiinflamatorios/uso terapéutico , Valerato de Betametasona/uso terapéutico , Dermatitis Irritante/tratamiento farmacológico , Femenino , Humanos , Viaje
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA